BILANCIO, Antonio
 Distribuzione geografica
Continente #
EU - Europa 4.799
NA - Nord America 3.426
AS - Asia 1.904
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 171
AF - Africa 23
OC - Oceania 3
Totale 10.596
Nazione #
US - Stati Uniti d'America 3.337
RU - Federazione Russa 2.736
SG - Singapore 659
IT - Italia 531
IE - Irlanda 518
CN - Cina 408
HK - Hong Kong 276
UA - Ucraina 254
BR - Brasile 238
GB - Regno Unito 232
VN - Vietnam 204
DE - Germania 195
FI - Finlandia 111
IN - India 93
TR - Turchia 83
KR - Corea 82
SE - Svezia 65
FR - Francia 40
GR - Grecia 38
CA - Canada 36
JP - Giappone 29
BE - Belgio 16
AR - Argentina 15
MX - Messico 11
BD - Bangladesh 10
AT - Austria 9
GT - Guatemala 9
IQ - Iraq 9
PK - Pakistan 9
NL - Olanda 8
ZA - Sudafrica 8
ES - Italia 7
CR - Costa Rica 6
ID - Indonesia 6
DK - Danimarca 5
EC - Ecuador 5
IR - Iran 5
NI - Nicaragua 5
SV - El Salvador 5
UZ - Uzbekistan 5
LT - Lituania 4
MA - Marocco 4
PL - Polonia 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AU - Australia 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BM - Bermuda 1
BZ - Belize 1
CI - Costa d'Avorio 1
DM - Dominica 1
EG - Egitto 1
GE - Georgia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TV - Tuvalu 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 10.425
Città #
Moscow 1.002
Dublin 518
San Jose 461
Chandler 401
Jacksonville 386
Singapore 334
Santa Clara 306
Hong Kong 272
Ashburn 200
Council Bluffs 180
Beijing 96
Ann Arbor 92
Naples 92
Seoul 82
Bengaluru 80
Princeton 71
Bremen 69
Ho Chi Minh City 67
Medford 57
Boardman 56
Caserta 56
Wilmington 49
Hanoi 44
Hefei 42
Milan 41
Roxbury 37
Woodbridge 35
Helsinki 33
San Mateo 33
Dallas 29
Los Angeles 22
Frattamaggiore 20
Da Nang 19
Marano 19
São Paulo 19
Munich 18
Brussels 16
Istanbul 16
Nanjing 16
The Dalles 16
Cambridge 15
Mountain View 15
Frankfurt am Main 14
Rome 14
Turku 14
New York 13
Seattle 12
Jinan 11
Houston 10
Hải Dương 10
Nanchang 10
Orta di Atella 10
Atlanta 9
Des Moines 9
Marigliano 9
Memphis 9
Miano 9
Zhengzhou 9
Guatemala City 8
London 8
Pozzuoli 8
Rio de Janeiro 8
Tokyo 8
Brooklyn 7
Columbus 7
Guangzhou 7
Kunming 7
Shenyang 7
Toronto 7
Volla 7
Auburn Hills 6
Belo Horizonte 6
Biên Hòa 6
Castelnuovo Cilento 6
Denver 6
Montreal 6
North Bergen 6
Orem 6
Amsterdam 5
Bắc Ninh 5
Cabo Frio 5
Forino 5
Haiphong 5
Hebei 5
Napoli 5
Norwalk 5
Queens 5
San Salvador 5
Stockholm 5
Tashkent 5
Thái Nguyên 5
Afragola 4
Araraquara 4
Aversa 4
Brasília 4
Chicago 4
Dhaka 4
Guarulhos 4
Hanover 4
Juiz de Fora 4
Totale 5.842
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 314
'Role of PI3-K signaling in steroid action’ 221
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 209
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 205
Effect of new androgen receptor antagonists (SARMs) in the treatment of human prostate cancer. 200
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 198
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 197
Breast cancer stem cells: The role of sex steroid receptors 196
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 195
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 194
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 190
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 182
Protein tyrosine phosphorylation and estradiol action 182
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 182
Integrating signals between cAMP and MAPK pathways in breast cancer 178
Sex steroid hormones act as growth factors 178
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 176
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 175
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 174
Action of vanadate on estrogen dependent MCF-7 cells. 172
'Steroid-activated PI3-K pathway in target cells'. 169
Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. 167
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 167
Rapid signalling pathway activation by androgens in epithelial and stromal cells 166
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 166
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 165
Phosphoinositide 3-kinase assay in breast cancer cell extracts. 165
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 161
Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. 160
Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients 159
Src is an initial target of sex steroid hormone action. 158
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 158
Ruolo di PI3K p110δ nell’attivazione linfocitaria e possibili implicazioni nella leucemia. 153
Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages 148
Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. 147
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 147
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 146
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 141
The androgen receptor in breast cancer 140
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 136
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 134
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 133
Essential role for the p110delta phosphoinositide 3-kinase in the allergic response 132
Non-genomic action of steroid hormones: More questions than answers 130
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice 128
Protein tyrosine phosphorylation and estradiol action 128
Signalling by PI3K isoforms: insights from gene-targeted mice 123
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. 122
Phosphoinositide 3-kinase in T cell activation and survival 122
Steroid activation of signal transducing pathways. 122
NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS. 121
Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition 120
Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells 120
Role of PI3-kinase signaling in steroid action 117
Signal transduction pathway activation by estradiol in human carcinoma-derived cell lines 113
The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells 112
Steroid activation of signalling pathways. 111
Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. 110
PI3-K in concert with Src induces S-phase entry of an oestradiol-stimulated human breast cancer cell line 110
Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells 110
The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. 109
Urinary neopterin and kynurenine in patients submitted to surgical stress with different inhalational anesthetics (halothane or isoflurane). 109
Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. 109
Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy 108
PI3-K in concert with Src induces S-phases entry of oestradiol-stimulated MCF-7 cells 106
Steroids hormones modulate DNA synthesis by non genomic action. 105
Steroid activation of signal transducing pathways. 105
Non genomic action of estradiol and progestin triggers DNA synthesis. 104
Role of a PKC in estradiol-induced G1/S progression of MCF-7 cells. 102
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models 95
Sex steroid hormones: cross-talks between receptors and signalling pathways. 89
Totale 10.596
Categoria #
all - tutte 33.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022424 0 0 0 4 151 10 10 13 22 44 35 135
2022/20231.283 76 31 11 139 152 116 9 120 559 15 28 27
2023/2024423 42 14 12 28 117 11 16 10 3 63 51 56
2024/20251.144 7 10 24 50 175 174 151 86 119 152 101 95
2025/20264.813 202 271 207 172 408 2.562 236 245 213 157 77 63
2026/2027742 31 69 326 316 0 0 0 0 0 0 0 0
Totale 10.596